HDO(Hetero-Duplex Oligonucleotide) Trial Campaign Announcement

HDO(Hetero-Duplex Oligonucleotide) Trial Campaign Announcement

In celebration of our 10th anniversary, we are thrilled to launch the HDO Trial Campaign as a heartfelt thank you to our valued customers and partners.

From April 1 to June 30, 2025, all orders placed during this period will be eligible to receive Hetero-Duplex Oligonucleotide (HDO) at 50% off the regular price.

 

・For corporate customers: Nippon Shokubai Co., Ltd.
👉 https://www.lifescience.shokubai.co.jp/news/1699/
 

・For academic customers: Nippon Gene Co., Ltd.
👉https://nippongene-oligo.com/news/2025/04/07/5727/

Visit each website for full details:

This is the perfect opportunity for those considering the adoption or evaluation of HDO nucleic acid drug technology.
Don’t miss out—take advantage of this limited-time offer to explore its potential for your projects!